Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Andrew Rawstron

Andrew Rawstron


Academic history

Andrew Rawstron, MD, PhD, is a Clinical Scientist at the Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Speaking on MRD in CLL

Dr Rawstron’s primary research focus is on predicting suboptimal responses of patients with chronic lymphocytic leukemia (CLL) with tools such as measurable residual disease (MRD).